United States: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

The February 2026 Compliance Deadline Is Here: Practical Steps For Substance Use Disorder Information Privacy Compliance

A February 2024 Final Rule ushered in significant updates to the federal confidentiality framework governing substance use disorder ("SUD") patient information established at 42 C.F.R. Part 2.

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Insurance Executives Sentenced To 20 Years For $233 Million ACA Enrollment Fraud Scheme

On February 18, the US Department of Justice (DOJ) announced that two insurance industry executives...

United States Healthcare

AF

ArentFox Schiff

FDA In Flux — February 2026 Newsletter

Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies.

United States Healthcare

M

Mintz

FDA Approves Accord's FILKRI (Filgrastim-laha), A Biosimilar To NEUPOGEN

On February 17, 2026, the U.S. Food and Drug Administration (FDA) approved FILKRI (filgrastim-laha)...

United States Healthcare

GP

Goodwin Procter LLP

Health-e Law Episode 21. J.P. Morgan Healthcare 2026 And Beyond: Technology Adoption And Strategic Transformation Under Cost Pressure (Podcast)

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

HHS OIG Releases New Medicare Advantage Compliance Program Guidance

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

New Oral Polio Vaccine Type 2 (NOPV2) Prequalified By WHO

Worldwide Healthcare

GP

Goodwin Procter LLP

HRSA Requests Comments On Future 340B Rebate Model Development

United States Healthcare

SR

McDermott Will & Schulte

Key Takeaways From The 2026 ASTP Annual Meeting

United States Healthcare

SR

McDermott Will & Schulte

A Path Forward For Health Systems Amid Retail Health Challenges

United States Healthcare

AC

Ankura Consulting Group LLC

Formycon And Lotus Expand Collaboration In Asia-Pacific Region To Pembrolizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

Trump Administration Pursues MFN Pricing For Prescription Drugs

United States Healthcare

CM

Crowell & Moring LLP

Senate HELP Committee Releases FDA Modernization Report: "Patients And Families First: Building The FDA Of The Future"

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

CDMO Platforms Will Be The Central Arena For MedTech M&A In 2026

United States Healthcare

AM

Alvarez & Marsal

New Year's Resolutions For Mediators (That Actually Change Outcomes)

United States Litigation

J

JAMS

Back To School 2025: Title IX Updates And How ADR Can Help Universities Resolve Disputes (Podcast)

United States Litigation

J

JAMS

What Foundations And Other Nonprofits Need To Know About The Foreign Agents Registration Act

United States Government

W

WilmerHale

What Europe's Renewable Energy Struggles Can Teach U.S. Regulators About Dispute System Design

United States Litigation

J

JAMS

Signed, Sealed, But Not Delivered? Don't Wonder About Taxes Under New Postal Service Rules

United States Tax

N

Nossaman LLP

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

FDA In Flux — February 2026 Newsletter

Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies.

United States Healthcare

M

Mintz

FDA Approves Accord's FILKRI (Filgrastim-laha), A Biosimilar To NEUPOGEN

On February 17, 2026, the U.S. Food and Drug Administration (FDA) approved FILKRI (filgrastim-laha)...

United States Healthcare

GP

Goodwin Procter LLP

SCOTUS Disarms President Trump In Trade War, Scrapping Tariff Authority

Today, the Supreme Court dealt a heavy blow to President Trump's trade agenda, concluding that the International Emergency Economic Powers Act...

Worldwide International

BS

Ballard Spahr LLP

New Oral Polio Vaccine Type 2 (NOPV2) Prequalified By WHO

Worldwide Healthcare

GP

Goodwin Procter LLP

Supreme Court Strikes Down IEEPA Tariffs; Refund Process To Be Determined

United States International

GP

Goodwin Procter LLP

HRSA Requests Comments On Future 340B Rebate Model Development

United States Healthcare

SR

McDermott Will & Schulte

Formycon And Lotus Expand Collaboration In Asia-Pacific Region To Pembrolizumab Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

Celebrating Black History Month -- Dr. Charles Drew, The Doctor Who Revolutionized Blood Storage

United States Employment

CL

Cowan Liebowitz & Latman PC

Trump Administration Pursues MFN Pricing For Prescription Drugs

United States Healthcare

CM

Crowell & Moring LLP

See more

Life Sciences, Biotechnology & Nanotechnology

FDA In Flux — February 2026 Newsletter

Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies.

United States Healthcare

M

Mintz

Formycon And Lotus Expand Collaboration In Asia-Pacific Region To Pembrolizumab Biosimilar

On February 11, 2026, Formycon AG and Lotus Pharmaceutical announced the execution of an exclusive license agreement directed to Formycon's pembrolizumab biosimilar candidate, FYB206.

United States Healthcare

GP

Goodwin Procter LLP

Celebrating Black History Month -- Dr. Charles Drew, The Doctor Who Revolutionized Blood Storage

Cowan, Liebowitz & Latman, P.C. celebrates Black History Month by celebrating the pioneering work of Dr. Charles Drew.

United States Employment

CL

Cowan Liebowitz & Latman PC

Trump Administration Pursues MFN Pricing For Prescription Drugs

United States Healthcare

CM

Crowell & Moring LLP

Senate HELP Committee Releases FDA Modernization Report: "Patients And Families First: Building The FDA Of The Future"

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

CDMO Platforms Will Be The Central Arena For MedTech M&A In 2026

United States Healthcare

AM

Alvarez & Marsal

Iowa Asks Eighth Circuit To Unblock Key Pharmacy Benefit Manager Reform Law Provisions

United States Healthcare

DM

Duane Morris LLP

Florida Federal Court Rules FDA Denial Of Citizen Petition Is Final Agency Action

United States Healthcare

DM

Duane Morris LLP

One-Way NDA vs. Mutual NDA For Life Sciences And Other Technology Companies: A Founder's Decision Guide

United States IP

C

Crowley Law LLC

See more

Healthcare

The February 2026 Compliance Deadline Is Here: Practical Steps For Substance Use Disorder Information Privacy Compliance

A February 2024 Final Rule ushered in significant updates to the federal confidentiality framework governing substance use disorder ("SUD") patient information established at 42 C.F.R. Part 2.

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Justice Department Sues OhioHealth For Restrictive All-or-Nothing Insurance Contracting Provisions

Amidst continued focus on healthcare competition and costs by the federal antitrust agencies and state attorneys general, the U.S. Department of Justice (DOJ), along with the Attorney General of Ohio, filed a civil antitrust lawsuit on February 20, 2026.

United States Anti-trust

M

Mintz

Insurance Executives Sentenced To 20 Years For $233 Million ACA Enrollment Fraud Scheme

On February 18, the US Department of Justice (DOJ) announced that two insurance industry executives...

United States Healthcare

AF

ArentFox Schiff

FDA In Flux — February 2026 Newsletter

United States Healthcare

M

Mintz

FDA Approves Accord's FILKRI (Filgrastim-laha), A Biosimilar To NEUPOGEN

United States Healthcare

GP

Goodwin Procter LLP

Health-e Law Episode 21. J.P. Morgan Healthcare 2026 And Beyond: Technology Adoption And Strategic Transformation Under Cost Pressure (Podcast)

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

HHS OIG Releases New Medicare Advantage Compliance Program Guidance

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

SCOTUS Disarms President Trump In Trade War, Scrapping Tariff Authority

Worldwide International

BS

Ballard Spahr LLP

New Oral Polio Vaccine Type 2 (NOPV2) Prequalified By WHO

Worldwide Healthcare

GP

Goodwin Procter LLP

See more

Latest Videos

See more

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Video)

W

WilmerHale

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Pay Transparency + The Power Of Preventive Strategies: Episode 3 — Pivoting Toward Preparation In The Life Sciences (Video)

JL

Jackson Lewis P.C.

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

When Health Plans Become Health Leaders: Hillary Galyean Rewrites The Health Plan Playbook (Video)

AM

Alvarez & Marsal

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More